|
 |
ZanaflexThis page contains recent news articles, when available, and an overview of Zanaflex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Zanaflex (when available) Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no direct effect on skeletal muscle fibers or the neuromuscular junction, and no major effect on monosynaptic spinal reflexes. The effects of tizanidine are greatest on polysynaptic pathways. The overall effect of these actions is thought to reduce facilitation of spinal motor neurons. For the management of increased muscle tone associated with spasticity Mechanism Of Action: Tizanidine reduces spasticity by increasing presynaptic inhibition of motor neurons through agonist action at a2-adrenergic receptor sites. News Articles on Tizanidine Acorda Therapeutics to Present at the 28th Annual JPMorgan Healthcare Conference - Jan 4, 2010 The Company's marketed products include Zanaflex Capsules® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Earthtimes (press release) Acorda Therapeutics Reports Third Quarter 2009 Financial Results - Nov 3, 2009 Gross sales are recognized using a deferred revenue recognition model, meaning Zanaflex Capsules and Zanaflex tablet shipments to wholesalers are recorded ... Reuters Acorda Therapeutics Inc. Reports Operating Results (10-Q) - Nov 6, 2009 Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate Fampridine-SR for the improvement of ... GuruFocus.com Generic Name: Tizanidine, Sirdalud, pain, muscle relaxer, muscle relaxant - Nov 11, 2009 Zanaflex is a short-acting drug indicated for the management of spasticity. It is used for conditions which cause the muscles to spasm such as multiple ... Pattaya Daily News Zacks Bull and Bear of the Day Highlights: Acorda Therapeutics, Canon, Big ... - Nov 6, 2009 ...company is extremely well-capitalized with over $290 million in cash, and management has commercial experience with current approved product Zanaflex. ... Zacks.com Acorda Therapeutics to Host Conference Call to Report Third Quarter 2009 ... - Oct 27, 2009 The Company's marketed products include Zanaflex Capsules® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Reuters Acorda Therapeutics, Inc. - SWOT Analysis - Oct 23, 2009 The increase was primarily due to increased net sales of its Zanaflex. The operating loss of the company was $39.4 million during FY2007, as compared to an ... PRMinds (press release) Acorda Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances ... - Nov 9, 2009 The company's marketed products include Zanaflex Capsules and Zanaflex tablets which are the short-acting drugs approved for the management of spasticity. ... PR-Inside.com (Pressemitteilung) Zanaflex Overnight - Sep 30, 2007 ...is the medication eliminated (through the skin, the intestine, the oral mucosa)? * Distribution - How is the study of Zanaflex Overnight and Drugs in the ... Sokwanele … Therapeutics Announces Expansion of Zanaflex Capsules(TM) Sales … - Oct 17, 2006 Acorda Therapeutics (Nasdaq: ACOR) announced today that it will expand its sales force to 65 people, including 52 area business managers who will call on ... Genetic Engineering News - Genetic Engineering News (press release) Acorda Therapeutics Sales Up - May 10, 2007 Net revenue increased to $8.3 million from $3.8 million in the comparable quarter last year, driven by sales of Zanaflex capsules and tablets. ... TheStreet.com - TheStreet.com (subscription) Acorda Therapeutics Reports Second Quarter 2006 Financial Results. - Aug 3, 2006 For the same quarter in 2005 we recognized gross sales of Zanaflex Capsules of $311000 and gross sales of Zanaflex tablets of $167000. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics Reports Fourth Quarter and Full Year 2007 … - Feb 11, 2008 Zanaflex Capsules shipments for the quarter ended December 31, 2007 were $14.1 million and Zanaflex tablet shipments were $1.3 million, providing total ... Lifescience-online Buy Zanaflex COD - Jun 9, 2007 ...though in common usage the two are at times confused. Contents [hide] * 1 Medicine development and safety testing * 2 Drug legislation and safety * 3 ... Sokwanele Q4 2005 and Year End Acorda Therapeutics Earnings Conference Call - … - Mar 31, 2006 This method means that Zanaflex product sales are recorded as deferred revenue when we ... Our remaining Zanaflex Capsule inventory had 36-month dating. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Acorda Therapeutics Launches ZANAFLEX CAPSULES for the … - Apr 4, 2005 HAWTHORNE, NY -- Acorda Therapeutics(R) announced today that it has launched ZANAFLEX(R) CAPSULES (tizanidine hydrochloride), a new, capsule formulation of ... $4.95 - Business Wire - ECNext Purchase Zanaflex Online - Nov 26, 2007 ...the legal jurisdiction. Medications are typically produced by pharmaceutical companies may do a number Purchase Zanaflex Online things:[2] * Carefully ... Sokwanele Zanaflex Buy - Mar 26, 2007 ...of Zanaflex Buy In the United States Pharmacopoeia.In the European Pharmacopoeia. Pharmacology as a Zanaflex Buy science is practiced by pharmacologists. ... Sokwanele Acorda Therapeutics Reports Third Quarter 2006 Financial Results. - Nov 2, 2006 For the quarter ended September 30, 2006, gross sales of Zanaflex Capsules[TM] ... For the same quarter in 2005 gross sales of Zanaflex Capsules were $0.9 ... Free with registration - Business Wire - AccessMyLibrary.com Zanaflex No Prescription - Sep 9, 2007 ...* Obtain a patent Zanaflex No Prescription the new medicine is altered slightly, this will slightly Zanaflex No Prescription the Zanaflex No Prescription ... Sokwanele Acorda completes enrollment in MS trial - Mar 3, 2006 Acorda also announced it has more than doubled its sales force for Zanaflex Capsules -- approved for the management of spasticity -- with a continued focus ... United Press International Purchase Zanaflex Without Prescription - Jun 17, 2007 ...of Dollars. To recoup this outlay Purchase Zanaflex Without Prescription companies may do Purchase Zanaflex Without Prescription number of things:[2] ... Sokwanele Acorda Therapeutics Reports First Quarter 2008 Financial Results - May 5, 2008 We reported favorable results of our Fampridine-SR Thorough QT study, continued to deliver solid Zanaflex Capsules sales performance, and entered into a ... Genetic Engineering News - Genetic Engineering News (press release) … minority stake in Acorda Therapeutics-Zanaflex from Acorda Therapeut... - Jan 19, 2006 Payments due to Paul Royalty Fund as a result of Zanaflex product sales to the ... Acorda Therapeutics' marketed products include Zanaflex Capsules ... Pay-Per-View - deals - Alacra Store Zanaflex COD - Aug 23, 2007 ...of drugs [edit] Footnotes 1. ^ ab Nagle, Hinter; Barbara Nagle (2005). Pharmacology: An Introduction. Boston: McGraw Hill. ISBN 0-07-312275-0. 2. ... Sokwanele Pronounced: ZAN-uh-flecks - Dec 1, 2005 Zanaflex relaxes the tense, rigid muscles caused by spasticity. ... Zanaflex causes drowsiness in almost half the people who use it. ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Acorda Therapeutics Reports Third Quarter 2008 Financial Results - Nov 4, 2008 Zanaflex Capsules and Zanaflex Tablets Shipments - Total Zanaflex Capsules ... This increase in expenses was primarily due to increases in Zanaflex Capsules ... International Business Times Zanaflex No Rx Required - Jul 15, 2007 ...produced by pharmaceutical companies may do a number of things:[2] * Zanaflex No Rx Required research the demand for their potential new product before ... Sokwanele Paul Royalty Fund Purchases Revenue Interest in Acorda's Zanaflex … - Jan 19, 2006 Zanaflex Capsules(TM) and Zanaflex(R) tablets are FDA-approved for the management of ... The company's marketed products include Zanaflex Capsules(TM) ... Free with registration - PR Newswire - AccessMyLibrary.com From Ambien to Zanaflex: making your medications work for you. |... - Dec 1, 2008 From Ambien to Zanaflex: making your medications work for you. ... find Paraplegia News articles. [ILLUSTRATION OMITTED] In this country we practice what's ... Pay-Per-View - Paraplegia News - HighBeam Research Buy On-line - zanaflex - Mar 2, 2007 CONDITIONS. If any of the 1187 patients in the bathroom. This medication should be reduced to a maximum tolerated. Notify your doctor or pharmacist. ... NETCOMPOSITES Acorda Therapeutics Reports First Quarter 2006 Financial Results - May 5, 2006 For the quarter ended March 31, 2006, gross sales of Zanaflex Capsules(TM) (tizanidine hydrochloride) were $2.3 million and gross sales of Zanaflex(R) ... Genetic Engineering News - Genetic Engineering News (press release) Zanaflex.(Drug overview) - Jan 22, 2007 Zanaflex relaxes the tense, rigid muscles caused by spasticity. It is prescribed for people with multiple sclerosis, spinal cord injuries, ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Acorda's Second Attempt At IPO Successful: $33M - Feb 13, 2006 About $7 million to $10 million is tabbed for sales and marketing activities for Zanaflex capsules and Fampridine-SR, assuming the FDA approves the latter. ... BioWorld Online - BioWorld Online … Therapeutics Announces Completion of Zanaflex Capsules(TM) Sales … - Jan 8, 2007 HAWTHORNE, NY -- Acorda Therapeutics, Inc.([R]) (Nasdaq: ACOR) reported today that it has completed the previously announced expansion of its sales force to ... $4.95 - Business Wire - ECNext … Revenue Interest in Acorda's Zanaflex Products. - PR Newswire |... - Jan 19, 2006 Paul Royalty Fund Purchases Revenue Interest in Acorda's Zanaflex Products. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Stock Market Update, IPO profiles, Earnings Call Transcripts,... - Oct 5, 2005 Zanaflex Capsules and Zanaflex tablets are short-acting drugs approved by the FDA ... Clinical trials conducted by Elan demonstrated that Zanaflex Capsules, ... 123Jump.com Acorda Therapeutics Reports Second Quarter 2007 Financial Results.( … - Aug 7, 2007 Zanaflex Gross Sales - For the quarter ended June 30, 2007, the Company reported gross sales of Zanaflex Capsules of $9.4 million and gross sales of ... Free with registration - Business Wire - AccessMyLibrary.com Q3 2007 Acorda Therapeutics Earnings Conference Call - Final. - Nov 6, 2007 Moving on to Zanaflex, we continue to see gratifying progress of our Zanaflex ... Shipments to wholesalers in the quarter were $11.9 million and Zanaflex ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com … 't switch dosage form with this drug.(LETTERS)(Zanaflex 4-mg... - Jul 10, 2006 I am a nurse in a multi-physician infectious disease/internal medicine clinic. I would like to share with you a dispensing error involving one of our ... $4.95 - Drug Topics - ECNext Acorda Therapeutics Reports First Quarter 2007 Financial Results - May 2, 2007 Zanaflex Gross Sales - For the first quarter ended March 31, 2007, the Company reported gross sales of Zanaflex Capsules of $7.6 million and gross sales of ... Genetic Engineering News - Genetic Engineering News (press release) Migraineurs Taking Zanaflex - MedWatch Alert - Apr 11, 2007 Acorda Therapeutics and the FDA have informed healthcare professionals of changes to the CONTRAINDICATIONS and WARNINGS Sections of the product labeling for ... HealthCentral.com Morning Alert for Acorda Therapeutics, Inc. - Jun 6, 2007 It markets Zanaflex Capsules and Zanaflex tablets, a short-acting drug indicated for the management of spasticity. The company's lead product candidate is ... $4.95 - M2 Presswire - ECNext Acorda Therapeutics Names Ian Smith, CFO of Vertex, to Board of … - Feb 5, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) Piper Jaffray Adds Acorda Therapeutics (ACOR) to Alpha List - Nov 19, 2007 The Company's marketed drug, Zanaflex Capsules, is United States Food and Drug Administration (FDA)-approved for the management of spasticity. ... StreetInsider.com - StreetInsider.com (subscription) Acorda 2Q loss grows on selling and research costs - Aug 5, 2008 Sales of Zanaflex, the company's only marketed product, grew 25 percent, to $13.1 million from $10.5 million. However, those sales were canceled out by ... Boston Globe Baum v. Barnhart, No. 05-CV-2335 (EDPa. 11/30/2005) - Nov 30, 2005 The doctor continued his Methadone, added Bextra and Zanaflex, and suggested that lumbar spine films were necessary (R. at 199). ... $2.95 - U.S. District Court, Eastern District... - VersusLaw Comments on: Migraine Triggers And Fighters - CBS News - Jun 18, 2008 If I can''t do nothing, I take a very smal dose of Zanaflex so I can function and it helps, but I still get the migraine. There are quite a few prescription ... CBS News Acorda Therapeutics Names John Librie Senior Vice President, Sales … - Apr 3, 2008 The Company's marketed products include Zanaflex Capsules(R) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) Loislaw Federal District Court Opinions - LAMAR v. BARNHART (EDNY … - Jun 21, 2005 He prescribed Zanaflex and Neurontin, and later increased the Plaintiff's Zanaflex dosage. (Tr. 232.) The Plaintiff was examined by a number of other ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Press Release: Acorda Therapeutics to Receive Up to $10 Million from ... - Nov 28, 2006 The Company's marketed products include Zanaflex Capsules™ (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... FierceBiotech Acorda Therapeutics 2006 Analyst Meeting - Final. - Jul 13, 2006 And then as I mentioned, we'll give you some background on the Zanaflex ... We have a commercial product, Zanaflex Capsules, and we've established a ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Loislaw Federal District Court Opinions - BAUM v. BARNHART (EDPa. … - Nov 30, 2005 The doctor continued his Methadone, added Bextra and Zanaflex, and suggested that lumbar spine films were necessary (R. at 199). ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Acorda Therapeutics Reports Fourth Quarter and Full Year 2006 … - Feb 20, 2007 In addition, sales of Zanaflex Capsules grew strongly in 2006, and we completed our second expansion of our sales force to 65 professionals. ... Genetic Engineering News - Genetic Engineering News (press release) … Files Lawsuit Against Apotex Corp. and Apotex Inc. Relating to... - Oct 11, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) … Files Lawsuit Against Apotex Corp. And Apotex Inc. Relating To... - Oct 15, 2007 The Company's marketed products include Zanaflex Capsules™ (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Medical News Today - Medical News Today (press release) … Pilot Pharmacokinetic Study Comparing Tizanidine Oral Spray to... - Apr 7, 2008 ...(PD) and safety results from its Pilot PK Study of its Oral Spray formulation of tizanidine compared to tizanidine tablets marketed as Zanaflex(R). ... Genetic Engineering News - Genetic Engineering News (press release) Acorda sinks on forecast wider 2008 loss - Feb 6, 2008 In the same SEC filing, Acorda said it expects to post a loss of $14 million during the fourth quarter, as sales of the muscle relaxant Zanaflex reached $12 ... Boston Globe Acorda Therapeutics at NewsMakers in the Biotech Industry - Final. - Sep 7, 2006 We are selling a commercial product - Zanaflex Capsules - which I will talk about later. And we have established a commercial infrastructure sales and ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Loislaw Federal District Court Opinions - LACROIX v. BARNHART (D. … - Jan 5, 2005 On October 16, 2001, Lacroix told Dr. Henderson that the Oxycontin was not working, and Dr. Henderson put Lacroix on Zanaflex and morphine in addition to ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Market Commentary on Acorda Therapeutics, Inc. - Feb 21, 2007 Ho also cited higher-than-expected sales of Zanaflex as a positive, and said the company, with $53.8 million in cash, has sufficient funds to get it through ... $4.95 - M2 Presswire - ECNext Merger and Acquisition Scenario - Jul 26, 2008 The Company's marketed drug, Zanaflex Capsules, is approved by United States Food and Drug Administration (FDA) for the management of spasticity. ... $250.00 - Revere Reports - Revere Delaware Case Law - AUSTIN v. CITY OF LEWES, 04A-10-001 (Del. … - Jun 29, 2005 In December, 2003, claimant was taking Zanaflex, a muscle relaxant, Oxycontin and ... He was on Nortriptyline, Oxycontin, Oxycodone, Zanaflex, Neurontin, ... Pay-Per-View - Delaware Case Law - Loislaw Merger and Acquisition Scenario - Dec 27, 2008 The Company's marketed drug, Zanaflex Capsules, is approved by United States Food and Drug Administration (FDA) for the management of spasticity. ... $250.00 - Revere Reports - Revere LACROIX v. BARNHART, 352 F.Supp.2d 100 (D.Mass. 01/05/2005) - Jan 5, 2005 On October 16, 2001, Lacroix told Dr. Henderson that the Oxycontin was not working, and Dr. Henderson put Lacroix on Zanaflex and morphine in addition to ... $2.95 - U.S. District Courts - VersusLaw Barnstable District Court - Sep 8, 2007 IRELAND, Sean E., 17, 245 Mitchell's Way, Hyannis; guilty plea to possession of cocaine with intent to distribute, possession of Zanaflex with intent to ... Cape Cod Times Merger and Acquisition Scenario - Jul 26, 2008 The Company's marketed drug, Zanaflex Capsules, is approved by United States Food and Drug Administration (FDA) for the management of spasticity. ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 12, 2008 The Company's marketed drug, Zanaflex Capsules, is approved by United States Food and Drug Administration (FDA) for the management of spasticity. ... $250.00 - Revere Reports - Revere Acorda Tackles Multiple Sclerosis - Apr 9, 2007 Zanaflex treats spasticity or muscular spasm, a condition associated with multiple sclerosis. Acorda's newer product is Fampridine-sr, which alleviates ... BusinessWeek Acorda Therapeutics Receives Additional $5 Million from Paul Capital ... - Feb 7, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) Barnstable District Court - Jul 21, 2007 SCHOFIELD, Carly, 18, 13 Heatherly Road, Marstons Mills; possession of cocaine, possession of oxycodone, possession of Zanaflex, possession of marijuana ... $2.95 - Cape Cod Times - NewsBank Merger and Acquisition Scenario - Jul 26, 2008 The Company's marketed drug, Zanaflex Capsules, is approved by United States Food and Drug Administration (FDA) for the management of spasticity. ... $250.00 - Revere Reports - Revere Flynn v. Commissioner of the Social Security Administration, No. 6:06... - Dec 27, 2007 Id. Dr. Kollmer refilled his prescriptions for Zanaflex, Percocet, OxyContin, Ambien and Zoloft, and recommended that Flynn remain off work at the time. ... $2.95 - U.S. District Court, Middle District of... - VersusLaw Merger and Acquisition Scenario - Dec 27, 2008 The Company's marketed drug, Zanaflex Capsules, is approved by United States Food and Drug Administration (FDA) for the management of spasticity. ... $250.00 - Revere Reports - Revere Acorda Therapeutics and FDA have notified healthcare professionals of... - Jun 1, 2007 Acorda Therapeutics and FDA have notified healthcare professionals of changes to the labeling for tizanidine tablets and capsules (Zanaflex). ... $9.94 - Formulary - Alacra Store Article: Porn Slipped Into Wash. Time Capsule - AP Online | HighBeam ... - Apr 27, 2007 Article: ACORDA GAINS ZANAFLEX RIGHTS FROM ELAN; NEW CAPSULE ... BIOWORLD Today; July 30, 2004 ; 700+ words ... ... disclosed, but Acorda gets sales, ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Tizanidine contraindicated for use with Luvox, Cipro.(Neurology) - Aug 1, 2007 Tizanidine, marketed as Zanaflex by Acorda Therapeutics, is a centrally ... The company's letter also pointed out that Zanaflex capsules and tablets are not ... $4.95 - Internal Medicine News - ECNext Acorda Therapeutics and FDA have notified healthcare professionals of... - Jun 1, 2007 Acorda Therapeutics and FDA have notified healthcare professionals of changes to the labeling for tizanidine tablets and capsules (Zanaflex). ... $9.94 - Formulary - Alacra Store Article: Porn Slipped Into Wash. Time Capsule - AP Online | HighBeam ... - Apr 27, 2007 Article: ACORDA GAINS ZANAFLEX RIGHTS FROM ELAN; NEW CAPSULE ... BIOWORLD Today; July 30, 2004 ; 700+ words ... ... disclosed, but Acorda gets sales, ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Acorda Therapeutics to Host Conference Call to Report Second - Aug 5, 2008 The Company's marketed products include Zanaflex Capsules(R) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Bloomberg Acorda Therapeutics to Present at the Piper Jaffray 20th Annual - Nov 25, 2008 The Company's marketed products include Zanaflex Capsules^® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Bloomberg Acorda Therapeutics Presents Positive Data from Preclinical - Jul 30, 2008 The Company's marketed products include Zanaflex Capsules(R) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Bloomberg Acorda Therapeutics to Present at RBC Capital Markets - Dec 4, 2008 The Company's marketed products include Zanaflex Capsules^® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Bloomberg Preclinical Study by Acorda Therapeutics Shows Efficacy of … - Feb 23, 2005 The Company's marketed products include Zanaflex(R), a short-acting drug indicated for ... For full prescribing information, please go to www.zanaflex.com. ... $4.95 - Business Wire - ECNext Lederman v. Analex Corp., No. 06-cv-00825-EWN-MEH (D.Colo. 09/12/ … - Sep 12, 2007 He further noted that Zanaflex, a muscle relaxant, was causing Plaintiff "quite a sleep hangover. ... (Id.) He took her off Zanaflex, Provigil and Lunesta, ... $2.95 - U.S. District Court, District of... - VersusLaw [U] Meece v. Barnhart, 192 Fed.Appx. 456, 2006 Fed.App. 0569N (6th... - Aug 8, 2006 Plaintiff testified that he was taking Vioxx and Zanaflex, as well as over the counter pain medication. Plaintiff testified that while he previously took ... $2.95 - U.S. Court of Appeals, Sixth Circuit - VersusLaw Moore v. Astrue, No. 07-0318-CV-W-REL-SSA (WDMo. 03/12/2008) - Mar 12, 2008 She takes Elavil for her depression and as well as Zanaflex. She also indicates she takes Soma ... Zanaflex helps her sleep some. Neurontin has not helped. ... $2.95 - U.S. District Court, Western District... - VersusLaw Acorda Therapeutics Announces Addition to Board of Directors. - Apr 7, 2005 The Company's marketed products include ZANAFLEX(R)CAPSULES (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... $4.95 - Business Wire - ECNext Dog shot, mother and two sons charged in drug bust - Jul 19, 2007 In Ireland's room, police found marijuana, two baggies of cocaine, five oxycodone pills, 5½ Zanaflex pills, a bottle of liquor, a safe with a digital scale ... Cape Cod Times Arkansas Workers' Compensation Decisions - SMITH v. O'REILLY … - Apr 18, 2006 Welsh prescribed Zanaflex, a medication used to treat muscle spasms. The claimant subsequently began working as a Merchandising Specialist, a position that ... Pay-Per-View - Arkansas Workers' Compensation Decisions - Loislaw Riley v. Barnhart, No. 04-CV-01015 (NDNY 03/05/2008) - Mar 5, 2008 He prescribed new medications, including Zanaflex and Vicoprofen (R. at 196). On January 12, 2004, Plaintiff followed-up with Dr. Sadrieh (R. 192-94). ... $2.95 - U.S. District Court, Northern District... - VersusLaw EU approves creation of world's top producer of generic medicines | … - May 27, 2005 Elan said sales of its Zanaflex muscle relaxant will fall in the second half of this year after Eon Labs Inc. starts shipping its generic version of the ... Pay-Per-View - AP Worldstream - HighBeam Research Tinkham v. Astrue, No. 06-C-486-C (WDWis. 06/07/2007) - Jun 7, 2007 Dr. Sterrett increased plaintiff's Neurontin dosage to 800mg, prescribed Zanaflex and asked him to return after he was home in August. AR 261-62. ... $2.95 - U.S. District Court, Western District... - VersusLaw Acorda Therapeutics' President and CEO Ron Cohen, MD Named Ernst … - Jun 29, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics to Present at the 2007 UBS Global Life Sciences … - Sep 19, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics to Present at the Acumen BioFin Rodman & … - Oct 31, 2007 The Company's marketed products include Zanaflex Capsules[TM] (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics to Present at Bank of America Health Care … - May 23, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics Responds to Third Point Letter - Feb 23, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) Acorda Therapeutics Provides Update on Clinical Development of … - Dec 8, 2006 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) Acorda Therapeutics Added to NASDAQ Biotechnology Index. - Nov 15, 2006 The Company's marketed products include Zanaflex Capsules[TM] (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Scientists Show Monoclonal Antibody Leads to Repair of Myelin Sheath ... - Oct 16, 2007 The Company's marketed products include Zanaflex Capsules[TM] (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics to Present at the Piper Jaffray Second Annual … - Jun 14, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics to Present at the Cowen and Company 27th Annual … - Mar 6, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) Acorda Therapeutics Announces Resignation of Mary Fisher - Jul 20, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Genetic Engineering News - Genetic Engineering News (press release) Acorda Therapeutics Elects John P. Kelley to Board of Directors - Dec 1, 2008 The Company's marketed products include Zanaflex Capsules ® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... International Business Times Acorda Therapeutics to Present at the Bear Stearns 20th Annual … - Sep 4, 2007 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics to Present at Two Upcoming Conferences. - May 8, 2006 The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. ... Free with registration - Business Wire - AccessMyLibrary.com Acorda Therapeutics at BIO Investor Forum 2006 - Final. - Oct 1, 2006 We're selling Zanaflex capsules into our preferred market, neurologists, spinal cord injury docs. We recently expanded that commercial infrastructure, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Brand Names/Synonyms: Zanaflex is also known by the following brand names and/or synonymsCHEMBANK1846; Pramiracetam; Sirdalud; Ternelin; Tizanidina [Inn-Spanish]; Tizanidine; Tizanidine Hcl; Tizanidinum [Inn-Latin]; Zanaflex Drug Category: Zanaflex is categorized under the following by the FDA: Muscle Relaxants; Anticonvulsants; Analgesics; Skeletal Muscle Relaxants; ATC:M03BX02 Dosage Forms: TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-8-thia-7,9-diazabicyclo[4.3.0]nona-2,4,6,9-tetraen-5-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
